AI Bias Analysis
4 models · Takes ~15 seconds
BioAge Labs said its investigational pill for cardiovascular risk prevention significantly reduced inflammation in an early study.
Source
Stat News
Opens original article in a new tab
A judge is expected to sentence OxyContin maker Purdue Pharma to forfeit $225 million to the Justice Department on Tuesday, clearing the way for the company to finalize a settlement…
The Trump administration has been heavily focused on combating purported fraud in federal health care programs.
BioAge bets on inflammation, a short Pfizer career, and more biotech news from The Readout
(MedPage Today) -- Note that some links may require registration or subscription. Research in older adults linked daytime napping patterns -- in the morning or longer and more frequent naps -- to a higher risk of mortality. (JAMA Network Open...
